Qol Holdings Co., Ltd.

3034

JP3266160005

Drug Retailers

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-14 am EDT			5-day change	1st Jan Change
1,511 ^JPY	-2.39%		-15.77%	-8.81%

Mar. 19	Qol to Secure 25 Billion Yen Bank Loan	MT
Mar. 18	Qol Holdings Co., Ltd. Announces Notice of Borrowing (Refinancing) of Funds	CI

Qol Holdings Co., Ltd. acquired KI Chozai Yakkyoku Ltd.

July 18, 2021

Qol Holdings Co., Ltd. (TSE:3034) acquired KI Chozai Yakkyoku Ltd. on July 15, 2021. Qol Holdings Co., Ltd. (TSE:3034) completed the acquisition of KI Chozai Yakkyoku Ltd. on July 15, 2021.

Latest news about Qol Holdings Co., Ltd.

Qol to Secure 25 Billion Yen Bank Loan	Mar. 19	MT
Qol Holdings Co., Ltd. Announces Notice of Borrowing (Refinancing) of Funds	Mar. 18	CI
Qol Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2024	Feb. 02	CI
Qol Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2024	Feb. 02	CI
Qol Holdings Co., Ltd. acquired KI Chozai Yakkyoku Ltd.	Dec. 10	CI
Qol Holdings Co., Ltd. acquired Art Co., Ltd. and AM Medical Co., Ltd. and Haraigawachozai Pharmacy Co., Ltd.	Nov. 21	CI
Japanese Shares End Lower; BoJ Expresses More Confidence in Wage Growth	23-10-03	MT
Qol Holdings Acquires 54,000 Shares in Daiichi Sankyo Espha	23-10-02	MT
Insmed Shares Rise After Announcing Positive Topline Results from Study of Lung Disease Treatment Arikayce	23-09-05	MT
Qol Holdings to Borrow Funds from Mizuho Bank	23-09-01	MT
Biogen's Alzheimer's Treatment Leqembi May be Eligible for Full Approval, US FDA's Advisers Say	23-06-07	MT
Strong Economic Reports Give Major Lift to Japanese Stocks; Rakuten Plans Up to 332 Billion Yen Equity Raise	23-05-17	MT
Daiichi Sankyo to Sell Pharmaceutical Subsidiary to Qol for 25 Billion Yen; Qol Ups Fiscal Year Earnings Projection	23-05-17	MT
Qol Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2023 and Fiscal Year Ending March 31, 2024	23-05-11	CI
Qol Holdings Co., Ltd. Provides Dividend Guidance for the Second Quarter End and Fiscal Year Ending March 31, 2024	23-05-11	CI
Qol Holdings Co., Ltd. Declares a Dividend for the Fiscal Year Ended March 31, 2023, Payable on June 13, 2023	23-05-11	CI
Qol Holdings Co., Ltd. Declares Commemorative Dividend for the Fiscal Year Ended March 31, 2023, Payable on June 13, 2023	23-05-11	CI
Qol Holdings Co., Ltd. Provides Commemorative Dividend Guidance for the Fiscal Year Ending March 31, 2023	23-02-03	CI
Qol Holdings Co., Ltd. Provides Dividend Guidance for the Full Year Ending of March 31, 2023	23-02-03	CI
Qol Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023	23-02-03	CI
Qol Holdings Co., Ltd. completed the acquisition of Power Pharmacy Co., Ltd. from Power Holdings, Inc.	23-01-30	CI
Qol Holdings Acquires 38 Dispensing Pharmacies with Power Pharmacy Takeover	23-01-09	MT
Qol Holdings Co., Ltd. concluded a share transfer agreement to acquire Power Pharmacy Co., Ltd. from Power Holdings, Inc.	23-01-05	CI
Qol Holdings Co., Ltd. acquired Hokusetsu Dispensing Pharmacy Co., Ltd..	22-11-06	CI
Qol Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023	22-11-04	CI

Qol Holdings Co.,Ltd., formerly Qol Co., Ltd. is engaged in the operation of insurance pharmacies and Business Process Outsourcing (BOP) commission business. The Company operates in two segments. The Insurance Pharmacy segment is engaged in the operation of insurance pharmacies, as well as the operation of convenience stores in hospitals. The BOP Commission segment is engaged in the Contract Sales Organization (CSO) business, Contract Research Organization (CRO) business, medical related business and the wholesale of medicine products, cosmetic products and daily necessities through its subsidiaries.

Sector

Drug Retailers

Calendar

2024-08-01 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Qol Holdings Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1,511 JPY

Average target price

2,700 JPY

Spread / Average Target

+78.69%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Retail - Drugs without Grocery

	1st Jan change	Capi.
QOL HOLDINGS CO., LTD.	-8.81%	370M
RAIA DROGASIL S.A.	-6.84%	8.83B
AIN HOLDINGS INC.	+35.23%	1.33B
NIHON CHOUZAI CO.,LTD.	+1.36%	272M
SALUS, LJUBLJANA, D. D.	+13.33%	232M
GREEN CROSS HEALTH LIMITED	-9.17%	87.2M
MEDICAL IKKOU GROUP CO.,LTD.	+20.94%	59.19M

Retail - Drugs without Grocery